PE20080550A1 - Sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina - Google Patents
Sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolinaInfo
- Publication number
- PE20080550A1 PE20080550A1 PE2007000891A PE2007000891A PE20080550A1 PE 20080550 A1 PE20080550 A1 PE 20080550A1 PE 2007000891 A PE2007000891 A PE 2007000891A PE 2007000891 A PE2007000891 A PE 2007000891A PE 20080550 A1 PE20080550 A1 PE 20080550A1
- Authority
- PE
- Peru
- Prior art keywords
- carbonyl
- quinolyl
- oxazolyl
- aminoethyl
- proline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
REFERIDA A LA SAL XINAFOATO DEL ETIL ESTER DE LA 1-[[5-(1(S)-AMINOETIL)-2-[8-METOXI-2-(TRIFLUOROMETIL)-5-QUINOLIL]-4-OXAZOLIL]CARBONIL]-4(R)-[(CICLOPROPIL-CARBONIL)AMINO]-L-PROLINA. TAMBIEN ESTA REFERIDA A LAS FORMAS POLIMORFICAS DE DICHA SAL, FORMA 1, 2 Y 3 Y EL DIHIDRATO DE LA FORMA 1. LA FORMA 1 TIENE UN PATRON DE DIFRACCION DE RAYOS X DE POLVO QUE TIENE PICOS MAXIMOS DE 6,1, 7,7, 13,0 Y 15,9 GRADOS 2 THETA; LA FORMA 2 TIENE PICOS MAXIMOS DE 10,6, 13,6, 19,1 Y 21,2; EL DIHIDRATO DE FORMA 1 TIENE PICOS MAXIMOS DE 8,2, 16,5, 18,5 Y 24,9; Y LA FORMA 3 TIENE PICOS MAXIMOS DE 4,6, 7,9, 12,1 Y 18,9. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES DE LAS VIAS RESPIRATORIAS TALES COMO ASMA, BRONQUITIS, BRONQUIOLITIS, FIBROSIS PULMONAR, ENTRE OTRAS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83005706P | 2006-07-11 | 2006-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080550A1 true PE20080550A1 (es) | 2008-06-13 |
Family
ID=38895717
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007000891A PE20080550A1 (es) | 2006-07-11 | 2007-07-11 | Sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina |
PE2011000903A PE20110391A1 (es) | 2006-07-11 | 2007-07-11 | Polimorfos de la sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011000903A PE20110391A1 (es) | 2006-07-11 | 2007-07-11 | Polimorfos de la sal xinafoato del etil ester de la 1-[[5-(1(s)-aminoetil)-2-[8-metoxi-2-(trifluorometil)-5-quinolil]-4-oxazolil]carbonil]-4(r)-[(ciclopropil-carbonil)amino]-l-prolina |
Country Status (22)
Country | Link |
---|---|
US (1) | US7919505B2 (es) |
EP (1) | EP2038277A2 (es) |
JP (2) | JP5097774B2 (es) |
KR (1) | KR20090026217A (es) |
CN (1) | CN101547920B (es) |
AR (1) | AR061890A1 (es) |
AU (1) | AU2007273007B2 (es) |
BR (1) | BRPI0712915A2 (es) |
CA (1) | CA2657902A1 (es) |
CL (1) | CL2007002020A1 (es) |
CO (1) | CO6190533A2 (es) |
EC (1) | ECSP099045A (es) |
IL (1) | IL196402A0 (es) |
MX (1) | MX2009000460A (es) |
NO (1) | NO20090646L (es) |
NZ (1) | NZ574070A (es) |
PE (2) | PE20080550A1 (es) |
RU (1) | RU2009104346A (es) |
SG (1) | SG173366A1 (es) |
TW (1) | TW200813040A (es) |
WO (1) | WO2008008327A2 (es) |
ZA (1) | ZA200900208B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7511062B2 (en) * | 2004-05-18 | 2009-03-31 | Schering Corporation | Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
JP2010500405A (ja) * | 2006-08-14 | 2010-01-07 | シェーリング コーポレイション | 2−(キノリン−5−イル)−4,5ジ置換−アゾール誘導体の合成のための方法および中間体 |
US20100324295A1 (en) * | 2007-07-10 | 2010-12-23 | Schering Corporation | Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof |
EP2176257A2 (en) * | 2007-07-10 | 2010-04-21 | Schering Corporation | Hydrogen chloride salt of a substituted 5-oxazol-2-yl-quinoline compound and a process for the production thereof |
JP5709101B2 (ja) * | 2010-09-01 | 2015-04-30 | 東レ・ファインケミカル株式会社 | ヒドロキシプロリン誘導体の製造法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2600644B2 (ja) * | 1991-08-16 | 1997-04-16 | 藤沢薬品工業株式会社 | チアゾリルベンゾフラン誘導体 |
US5352707A (en) * | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
US5472964A (en) * | 1992-12-22 | 1995-12-05 | Merck Frosst Canada, Inc. | Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
IL126557A (en) * | 1996-05-20 | 2002-09-12 | Darwin Discovery Ltd | Quinoline (thio) carboxamides inhibiting TNF or PDE-IV and pharmaceutical preparations containing them |
AU722662B2 (en) * | 1996-05-20 | 2000-08-10 | Darwin Discovery Limited | Quinoline sulfonamides as TNF inhibitors and as PDE-IV inhibitors |
US6069151A (en) * | 1996-11-06 | 2000-05-30 | Darwin Discovery, Ltd. | Quinolines and their therapeutic use |
US20050017134A1 (en) * | 2003-07-24 | 2005-01-27 | Hooper Patricia E. | Glass and bottle holders |
US7511062B2 (en) * | 2004-05-18 | 2009-03-31 | Schering Corporation | Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
JP2008534611A (ja) | 2005-03-30 | 2008-08-28 | シェーリング コーポレイション | 抗コリン作用薬、コルチコステロイドおよび長時間作用性βアゴニストを合わせる薬物および方法 |
-
2007
- 2007-07-10 US US11/775,383 patent/US7919505B2/en not_active Expired - Fee Related
- 2007-07-10 EP EP07836037A patent/EP2038277A2/en not_active Withdrawn
- 2007-07-10 RU RU2009104346/04A patent/RU2009104346A/ru not_active Application Discontinuation
- 2007-07-10 CA CA002657902A patent/CA2657902A1/en not_active Abandoned
- 2007-07-10 SG SG2011050341A patent/SG173366A1/en unknown
- 2007-07-10 AU AU2007273007A patent/AU2007273007B2/en not_active Ceased
- 2007-07-10 NZ NZ574070A patent/NZ574070A/en not_active IP Right Cessation
- 2007-07-10 CN CN2007800336203A patent/CN101547920B/zh not_active Expired - Fee Related
- 2007-07-10 JP JP2009519488A patent/JP5097774B2/ja not_active Expired - Fee Related
- 2007-07-10 MX MX2009000460A patent/MX2009000460A/es not_active Application Discontinuation
- 2007-07-10 KR KR1020097002657A patent/KR20090026217A/ko not_active Application Discontinuation
- 2007-07-10 BR BRPI0712915-7A patent/BRPI0712915A2/pt not_active IP Right Cessation
- 2007-07-10 WO PCT/US2007/015715 patent/WO2008008327A2/en active Application Filing
- 2007-07-11 CL CL200702020A patent/CL2007002020A1/es unknown
- 2007-07-11 AR ARP070103086A patent/AR061890A1/es not_active Application Discontinuation
- 2007-07-11 TW TW096125280A patent/TW200813040A/zh unknown
- 2007-07-11 PE PE2007000891A patent/PE20080550A1/es not_active Application Discontinuation
- 2007-07-11 PE PE2011000903A patent/PE20110391A1/es not_active Application Discontinuation
-
2009
- 2009-01-08 IL IL196402A patent/IL196402A0/en unknown
- 2009-01-09 EC EC2009009045A patent/ECSP099045A/es unknown
- 2009-01-09 ZA ZA200900208A patent/ZA200900208B/xx unknown
- 2009-02-10 NO NO20090646A patent/NO20090646L/no not_active Application Discontinuation
- 2009-02-11 CO CO09013387A patent/CO6190533A2/es not_active Application Discontinuation
-
2012
- 2012-06-13 JP JP2012133753A patent/JP2012214482A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
TW200813040A (en) | 2008-03-16 |
NZ574070A (en) | 2011-12-22 |
CN101547920A (zh) | 2009-09-30 |
US20080027101A1 (en) | 2008-01-31 |
CN101547920B (zh) | 2012-06-27 |
AU2007273007A1 (en) | 2008-01-17 |
AU2007273007B2 (en) | 2012-11-01 |
US7919505B2 (en) | 2011-04-05 |
IL196402A0 (en) | 2009-09-22 |
BRPI0712915A2 (pt) | 2012-10-09 |
SG173366A1 (en) | 2011-08-29 |
PE20110391A1 (es) | 2011-06-22 |
KR20090026217A (ko) | 2009-03-11 |
AR061890A1 (es) | 2008-10-01 |
WO2008008327A2 (en) | 2008-01-17 |
ECSP099045A (es) | 2009-02-27 |
EP2038277A2 (en) | 2009-03-25 |
CO6190533A2 (es) | 2010-08-19 |
CA2657902A1 (en) | 2008-01-17 |
JP5097774B2 (ja) | 2012-12-12 |
CL2007002020A1 (es) | 2008-02-22 |
WO2008008327A3 (en) | 2008-03-06 |
ZA200900208B (en) | 2010-01-27 |
MX2009000460A (es) | 2009-01-27 |
JP2009542811A (ja) | 2009-12-03 |
RU2009104346A (ru) | 2010-08-20 |
NO20090646L (no) | 2009-04-07 |
JP2012214482A (ja) | 2012-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007002099A1 (es) | Compuestos derivados de 3h-espiro(1-benzofuran-2,4'-piperidina); proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso para el tratamiento de enfermedades respiratorias, tales como epoc y asma. | |
CL2007002708A1 (es) | Compuestos derivados de pirrolo[2,3-b]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, caquexia, trastornos inflamatorios, entre otros. | |
CL2007003765A1 (es) | Compuestos derivados de 2-oxo-4-hidroxi-benzotiazol; procesode preparacion; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, bronquitis, asma y bronquiectasias. | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
CL2007003754A1 (es) | Compuestos derivados de aril(heteroaril)alquil-amina; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como bronquitis, enfisema pulmonar y epoc. | |
CL2007002689A1 (es) | Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras. | |
CL2007002513A1 (es) | Compuestos derivados de isoindolina sustituidos, compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento y prevencion de enfermedades tales como cancer, dolor, degeneracion macular, entre otras. | |
AU2012243329A8 (en) | 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use | |
CL2007003635A1 (es) | Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer. | |
CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
CL2012001464A1 (es) | Compuestos derivados de (2-amino-5,5-difluor-5,6-dihidro-4h-[1,3]oxazin-4-il)-fenilamida, inhibidores bace1 y/o bace2; composicion farmaceutica; procedimiento de preparacion; y uso en el tratamiento terapeutico y/o profilactico de enfermedades tales como alzheimer y diabetes. | |
CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
CL2007002274A1 (es) | Compuestos derivados del acido (3-amino-1,2,3,4-tetrahidro-9h-carbazol-9-il)-acetico; composicion farmaceutica; y uso para la prevencion y/o tratamiento de enfermedades alergicas e inmunes, tales como asma, epoc y rinitis entre otras. | |
WO2007122580A3 (en) | Compositions of phenylephrine useful for treatment of respiratory illness | |
UY30411A1 (es) | Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
WO2009149486A3 (en) | Compounds for treating beta-amyloidoses | |
CL2014002386A1 (es) | Compuesto inhibidor de cinasa de fosfoinositida 3 en forma anhidra cristalina solida; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento o prevencion de enfermedades tales como epoc, asma, entre otras. | |
EA201400392A1 (ru) | ПРОИЗВОДНЫЕ 6-ЗАМЕЩЕННЫХ ТРИАЗОЛОПИРИДАЗИНОВ КАК АГОНИСТЫ Rev-Erb | |
CL2007001481A1 (es) | Compuestos derivados de pirrolidina sustituidas, inhibidores de proteasa activadora de canal; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como fibrosis quistica, bronquitis cronica, epoc, asma e infecciones de las vias r | |
WO2007093880A3 (en) | Novel pyrone-indole derivatives and process for their preparation | |
WO2008076954A3 (en) | Heterocycle compounds and methods of use thereof | |
CL2007003346A1 (es) | Compuestos derivados de 2,5-dihidro-3h-pirazolo[4,3-c]piridazin-3-ona; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como sindrome de abstinencia a una sustancia, tras | |
IL197575A (en) | A method for removing adult stem cells from the blood, using them to prepare drugs for the treatment of lesions, and a medical preparation containing these adult GES cells | |
HK1093746A1 (en) | Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production | |
CL2007003190A1 (es) | Compuestos derivados de arilsulfonil-pirrolidinas; procedimiento de obtencion; composicion farmaceutica; y uso en la prevencion o tratamiento de enfermedades tales como psicosis, depresion, alzheimer, entre otras. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |